PHARM@21
ActiveSummary
PHARM@21 has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €51,752. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 48% of 10522 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 28 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
History
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Peer companies
Historical observationOf the 14,732 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 14,732 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €2 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €47,927 | €48,828 | €36,020 | €27,432 | €43,427 | ▲ 58.3% |
| Other operating charges640/8 | - | €4,583 | €5,787 | €7,537 | €77,148 | ▲ 924% |
| Gross operating margin9900 | €154,204 | €193,037 | €152,603 | €187,225 | €222,925 | ▲ 19.1% |
| Operating profit (loss)9901 | €101,645 | €139,626 | €110,796 | €152,256 | €102,350 | ▼ 32.8% |
| Financial income75/76B | - | €0 | €90 | €2,103 | €4,619 | ▲ 120% |
| Recurring financial income75 | €0 | €0 | €90 | €2,103 | €4,619 | ▲ 120% |
| Financial charges65/66B | - | €9,632 | €17,221 | €30,373 | €37,008 | ▲ 21.8% |
| Recurring financial charges65 | €16,764 | €9,632 | €17,221 | €30,373 | €37,008 | ▲ 21.8% |
| Profit (loss) for the period before taxes9903 | €84,881 | €129,994 | €93,665 | €123,986 | €69,961 | ▼ 43.6% |
| Income taxes67/77 | €23,494 | €38,167 | €20,769 | €35,483 | €18,209 | ▼ 48.7% |
| Profit (loss) for the period9904 | €61,387 | €91,826 | €72,896 | €88,503 | €51,752 | ▼ 41.5% |
| Profit (loss) for the period to be appropriated9905 | €61,387 | €91,826 | €72,896 | €88,503 | €51,752 | ▼ 41.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.8m | €2.0m | €2.7m | €3.1m | €3.2m | ▲ 3.5% |
| Fixed assets21/28 | €1.8m | €2.0m | €2.5m | €2.7m | €3.2m | ▲ 17.8% |
| Tangible fixed assets22/27 | €706,562 | €881,813 | €1.4m | €1.6m | €2.1m | ▲ 30.1% |
| Land and buildings22 | - | €876,918 | €1.4m | €1.6m | €2.1m | ▲ 30.2% |
| Plant, machinery and equipment23 | - | €1,192 | €1,778 | €1,284 | €790 | ▼ 38.5% |
| Furniture and vehicles24 | - | €3,703 | €2,280 | €1,311 | €1,283 | ▼ 2.1% |
| Financial fixed assets28 | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | = |
| Current assets29/58 | €9,594 | €16,883 | €151,912 | €399,055 | €25,834 | ▼ 93.5% |
| Amounts receivable within one year40/41 | - | - | €13,231 | €29,098 | €8,060 | ▼ 72.3% |
| Other amounts receivable41 | - | - | €13,231 | €29,098 | €8,060 | ▼ 72.3% |
| Current investments50/53 | - | - | - | €130,000 | - | - |
| Cash at bank and in hand54/58 | €4,241 | €9,303 | €134,451 | €230,942 | €10,964 | ▼ 95.3% |
| Deferred charges and accrued income490/1 | - | €7,580 | €4,230 | €9,015 | €6,810 | ▼ 24.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.8m | €2.0m | €2.7m | €3.1m | €3.2m | ▲ 3.5% |
| Equity10/15 | €839,751 | €931,577 | €998,273 | €1.1m | €1.1m | ▲ 5.3% |
| Contributions10/11 | €6,200 | €6,200 | - | - | €6,200 | - |
| Capital10 | - | €6,200 | - | - | - | - |
| Issued capital100 | - | €18,600 | - | - | - | - |
| Uncalled capital101 | - | €12,400 | - | - | - | - |
| Reserves13 | €833,551 | €925,377 | €998,273 | €1.1m | €1.1m | ▲ 4.8% |
| Non-distributable reserves130/1 | - | €1,860 | - | - | - | - |
| Legal reserve130 | - | €1,860 | - | - | - | - |
| Distributable reserves133 | - | €923,517 | €998,273 | €1.1m | €1.1m | ▲ 4.8% |
| Amounts payable17/49 | €976,406 | €1.1m | €1.7m | €2.0m | €2.1m | ▲ 2.5% |
| Amounts payable after more than one year17 | €562,500 | €646,786 | €1.2m | €1.2m | €1.3m | ▲ 12.2% |
| Financial debts170/4 | - | €646,786 | €1.2m | €1.2m | €1.3m | ▲ 12.2% |
| Amounts payable within one year42/48 | €400,970 | €407,397 | €519,656 | €806,804 | €691,477 | ▼ 14.3% |
| Current portion of amounts payable after more than one year42 | - | €101,429 | €123,929 | €115,179 | €142,678 | ▲ 23.9% |
| Financial debts43 | - | €16,688 | €17,362 | €23,447 | €20,885 | ▼ 10.9% |
| Credit institutions430/8 | - | €16,688 | €17,362 | €23,447 | €20,885 | ▼ 10.9% |
| Trade debts44 | €6,876 | €255,198 | €321,989 | €604,689 | €430,797 | ▼ 28.8% |
| Suppliers440/4 | - | €255,198 | €321,989 | €604,689 | €430,797 | ▼ 28.8% |
| Taxes, remuneration and social security45 | - | €6,167 | €3,055 | €3,531 | €2,986 | ▼ 15.4% |
| Taxes450/3 | - | €6,167 | €3,055 | €3,531 | €2,986 | ▼ 15.4% |
| Other amounts payable47/48 | - | €27,915 | €53,321 | €59,959 | €94,131 | ▲ 57.0% |
| Accrued charges and deferred income492/3 | - | €12,936 | €5,286 | €3,586 | €22,489 | ▲ 527% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €61,387 | €91,826 | €72,896 | €88,503 | €51,752 | ▼ 41.5% |
| + Depreciation and write-downs630 | €47,927 | €48,828 | €36,020 | €27,432 | €43,427 | ▲ 58.3% |
| Operating cash flow (approximation) | €109,314 | €140,654 | €108,916 | €115,935 | €95,180 | ▼ 17.9% |
| Investment in fixed assets (approximation) | - | -€224,078 | -€584,493 | -€196,577 | -€525,067 | ▼ 167% |
| Change in cash | - | €5,063 | €125,147 | €96,492 | -€219,979 | ▼ 328% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
04-09
State Gazette act
Appointments: VAN BREMPT Famke, VAN BREMPT Kato and 2 othersDeclaration · Power of attorney · Purpose change9 facts ▸
- Director appointment, VAN BREMPT Famke (bijkomende niet statutaire bestuurder)
- Director appointment, VAN BREMPT Kato (bijkomende niet statutaire bestuurder)
- Declaration, 10-08-2026
- Director appointment, VAN BREMPT Joris Jozef Maria (managing director)
- Director appointment, VLAEMINCK Tina Irma (managing director)
- Other statement, coördinatie statuten, opdracht gegeven aan notaris om coördinatie op te maken, te ondertekenen en neer te leggen
- Power of attorney, Torck
- General meeting, 27-08-2026
- Purpose change
About the unread acts
Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
Board 2
Day-to-day management 2
Not every act has been read: a resignation may be missing here
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41042E0323/00M000 | Flanders | 2,687 m² | 1 · 152 m² | 7.5 m · 2 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
| Name | Functions and periods |
|---|---|
| Famke VAN BREMPT |
|
| Kato VAN BREMPT |
|
| Joris Jozef Maria VAN BREMPT |
|
| Tina Irma VLAEMINCK |
|
Articles of association
Full purpose (10 activities)
- Optimaliseren van vermogen
- Het oprichten, het promoveren} valoriseren, inrichten, uitrusten, exploiteren en beheren van beboude of onbebouwde onroerende goederen en van lichamelijke of onlichamelijke roerende goederen , met inbegrip van de handel onder al zijn vormen in die goederen; zo ondermeer:
- Het verstrekken van raad en bijstand aan ondernemingen; het beoefenen, adviseren en participeren in de industriële-en handelssector; het optreden als tussenpersoon bij overname van ondernemingen;
- Het aan-en verkopen, oprichten, uitrusten, bouwen, valoriseren, huren en verhuren van alle onroerende goederen, kortom het realiseren van onroerend goed transacties voor eigenrekening;
- Het aan- en verkopen van evenals inschrijven op en deelnemen aan alle mogelijke roerende waarden en effecten die worden uitgegeven door ondernemingen of door overheden;
- Het ontwikkelen, verwerven, verhandelen of in licentie geven van octrooien, patenten, know-how, merken en modellen, kortom alle soorten intellectuele rechten en aanverwante immateriële vaste activa, al dan niet met het verrichten van wetenschappelijk onderzoek dat daarop betrekking heeft;
- Bij wijze van inbreng in natura of in speciën op gelijke welke wij ze participeren in alle bestaande of op te richten rechtspersonen in Belgie of in het buitenland, al dan niet met een gelijk voorwerp als het hare evenals het waarnemen van het bestuur of als vereffenaar, toezicht en controle in alle vennootschappen, waarmee al dan niet een band van deelneming bestaat evenals het verstrekken van zakelijke en/of persoonlijke zekerheden en kredieten, met uitzondering van elke financiële verrichting onder welke vorm ook die valt onder het toezicht van de commissie voor het Bank-, Financie- en Assurantiewezen.
- Het opzoeken, selecteren, recruteren van personeel voor ondernemingen;
- Het lanceren van nieuwe producten en ontwikkelingsprojecten;
- Het uitvoeren van marketing-enquêtes, promotionele en verkoopacties alsmede het creëren, lanceren, begeleiden van nieuwe markten voor ondernemingen.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-03-2025 list no shareholders, and no other source names one.
Holdings 1
- APOTEEK KELLESsubsidiarySourceown accounts 31-03-2025100%
According to the annual accounts to 31-03-2025 of PHARM@21 and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
4 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 2,004 EUR awarded · 2,004 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 2,004 EUR | 2,004 EUR |
Similar companies · same sector, comparable size
Identification & contact
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.